You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 64 No. 3, March 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Review
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (24)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Similar articles in this journal
 Topic Collections
 •Neurology
 •Depression
 •Review
 •Alert me on articles by topic

The Role of Dopamine in the Pathophysiology of Depression

Boadie W. Dunlop, MD; Charles B. Nemeroff, MD, PhD

Arch Gen Psychiatry. 2007;64(3):327-337.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

Multiple sources of evidence support a role for diminished dopaminergic neurotransmission in major depression. The physiological alterations underlying reduced dopamine (DA) signaling could result from either diminished DA release from presynaptic neurons or impaired signal transduction, either due to changes in receptor number or function and/or altered intracellular signal processing. There are data supporting each of these mechanisms, although interpretation of previous research is confounded by issues around study population, medication status, and technological limitations. In some patients with depression, DA-related disturbances improve by treatment with antidepressants, presumably by acting on serotonergic or noradrenergic circuits, which then affect DA function. However, most antidepressant treatments do not directly enhance DA neurotransmission, which may contribute to residual symptoms, including impaired motivation, concentration, and pleasure. Animal models of major depression show considerable responsiveness to manipulations of DA neurotransmission. Several studies, including postmortem investigations, particularly . . . [Full Text of this Article]

DOPAMINERGIC PATHWAYS IN THE CENTRAL NERVOUS SYSTEM

DOPAMINE SYNTHESIS AND SIGNALING

ANIMAL MODELS OF DOPAMINE FUNCTION IN DEPRESSION

HUMAN GENETIC AND NEUROCHEMICAL STUDIES

DISTURBED REWARD SYSTEM FUNCTION IN DEPRESSION

POSTMORTEM FINDINGS

NEUROIMAGING FINDINGS

CLINICAL THERAPEUTICS

SEROTONIN-DOPAMINE INTERACTION

CONCLUSIONS

AUTHOR INFORMATION

Author Affiliations: Department of Psychiatry and Behavioral Sciences, Emory University, Atlanta, Ga.


RELATED LETTER

Dopamine and Depression
Andrew J. Saxon
Arch Gen Psychiatry. 2007;64(9):1101.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Abnormal temporal difference reward-learning signals in major depression
Kumar et al.
Brain 2008;131:2084-2093.
ABSTRACT | FULL TEXT  

Adjunctive Aripiprazole for Bupropion-Resistant Major Depression
Sokolski
The Annals of Pharmacotherapy 2008;42:1124-1129.
ABSTRACT | FULL TEXT  

Neural Response to Catecholamine Depletion in Unmedicated Subjects With Major Depressive Disorder in Remission and Healthy Subjects
Hasler et al.
Arch Gen Psychiatry 2008;65:521-531.
ABSTRACT | FULL TEXT  

Recent Findings in the Pathophysiology of Depression
Nemeroff
Focus 2008;6:3-14.
FULL TEXT  

Dopamine and Depression
Saxon
Arch Gen Psychiatry 2007;64:1101-1101.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.